396 related articles for article (PubMed ID: 15611427)
1. Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors.
Gilliet M; Conrad C; Geiges M; Cozzio A; Thürlimann W; Burg G; Nestle FO; Dummer R
Arch Dermatol; 2004 Dec; 140(12):1490-5. PubMed ID: 15611427
[TBL] [Abstract][Full Text] [Related]
2. Enhanced type I interferon signaling and recruitment of chemokine receptor CXCR3-expressing lymphocytes into the skin following treatment with the TLR7-agonist imiquimod.
Wenzel J; Uerlich M; Haller O; Bieber T; Tueting T
J Cutan Pathol; 2005 Apr; 32(4):257-62. PubMed ID: 15769273
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor 7/8 agonists stimulate plasmacytoid dendritic cells to initiate T
Garzorz-Stark N; Lauffer F; Krause L; Thomas J; Atenhan A; Franz R; Roenneberg S; Boehner A; Jargosch M; Batra R; Mueller NS; Haak S; Groß C; Groß O; Traidl-Hoffmann C; Theis FJ; Schmidt-Weber CB; Biedermann T; Eyerich S; Eyerich K
J Allergy Clin Immunol; 2018 Apr; 141(4):1320-1333.e11. PubMed ID: 28935206
[TBL] [Abstract][Full Text] [Related]
4. Langerin(neg) conventional dendritic cells produce IL-23 to drive psoriatic plaque formation in mice.
Wohn C; Ober-Blöbaum JL; Haak S; Pantelyushin S; Cheong C; Zahner SP; Onderwater S; Kant M; Weighardt H; Holzmann B; Reizis B; Becher B; Prens EP; Clausen BE
Proc Natl Acad Sci U S A; 2013 Jun; 110(26):10723-8. PubMed ID: 23754427
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of pathogenesis of imiquimod-induced skin inflammation in the mouse: a role for interferon-alpha in dendritic cell activation by imiquimod.
Ueyama A; Yamamoto M; Tsujii K; Furue Y; Imura C; Shichijo M; Yasui K
J Dermatol; 2014 Feb; 41(2):135-43. PubMed ID: 24387343
[TBL] [Abstract][Full Text] [Related]
6. Disease-independent skin recruitment and activation of plasmacytoid predendritic cells following imiquimod treatment.
Urosevic M; Dummer R; Conrad C; Beyeler M; Laine E; Burg G; Gilliet M
J Natl Cancer Inst; 2005 Aug; 97(15):1143-53. PubMed ID: 16077073
[TBL] [Abstract][Full Text] [Related]
7. Azithromycin impairs TLR7 signaling in dendritic cells and improves the severity of imiquimod-induced psoriasis-like skin inflammation in mice.
Huang SW; Chen YJ; Wang ST; Ho LW; Kao JK; Narita M; Takahashi M; Wu CY; Cheng HY; Shieh JJ
J Dermatol Sci; 2016 Oct; 84(1):59-70. PubMed ID: 27449383
[TBL] [Abstract][Full Text] [Related]
8. Plasmacytoid dendritic cells produce cytokines and mature in response to the TLR7 agonists, imiquimod and resiquimod.
Gibson SJ; Lindh JM; Riter TR; Gleason RM; Rogers LM; Fuller AE; Oesterich JL; Gorden KB; Qiu X; McKane SW; Noelle RJ; Miller RL; Kedl RM; Fitzgerald-Bocarsly P; Tomai MA; Vasilakos JP
Cell Immunol; 2002; 218(1-2):74-86. PubMed ID: 12470615
[TBL] [Abstract][Full Text] [Related]
9. Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production.
Nestle FO; Conrad C; Tun-Kyi A; Homey B; Gombert M; Boyman O; Burg G; Liu YJ; Gilliet M
J Exp Med; 2005 Jul; 202(1):135-43. PubMed ID: 15998792
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic targeting of Toll-like receptors: a review of Toll-like receptors and their signaling pathways in psoriasis.
Rahmani F; Rezaei N
Expert Rev Clin Immunol; 2016 Dec; 12(12):1289-1298. PubMed ID: 27359083
[TBL] [Abstract][Full Text] [Related]
11. Psoriasis induced by topical imiquimod.
Wu JK; Siller G; Strutton G
Australas J Dermatol; 2004 Feb; 45(1):47-50. PubMed ID: 14961909
[TBL] [Abstract][Full Text] [Related]
12. Plasmacytoid dendritic cells orchestrate TLR7-mediated innate and adaptive immunity for the initiation of autoimmune inflammation.
Takagi H; Arimura K; Uto T; Fukaya T; Nakamura T; Choijookhuu N; Hishikawa Y; Sato K
Sci Rep; 2016 Apr; 6():24477. PubMed ID: 27075414
[TBL] [Abstract][Full Text] [Related]
13. Aldara®-induced skin inflammation: studies of patients with psoriasis.
Vinter H; Iversen L; Steiniche T; Kragballe K; Johansen C
Br J Dermatol; 2015 Feb; 172(2):345-53. PubMed ID: 24980460
[TBL] [Abstract][Full Text] [Related]
14. Obesity exacerbates imiquimod-induced psoriasis-like epidermal hyperplasia and interleukin-17 and interleukin-22 production in mice.
Kanemaru K; Matsuyuki A; Nakamura Y; Fukami K
Exp Dermatol; 2015 Jun; 24(6):436-42. PubMed ID: 25777289
[TBL] [Abstract][Full Text] [Related]
15. TLR-activated plasmacytoid dendritic cells inhibit breast cancer cell growth in vitro and in vivo.
Wu J; Li S; Yang Y; Zhu S; Zhang M; Qiao Y; Liu YJ; Chen J
Oncotarget; 2017 Feb; 8(7):11708-11718. PubMed ID: 28052019
[TBL] [Abstract][Full Text] [Related]
16. Aldara-induced psoriasis-like skin inflammation: isolation and characterization of cutaneous dendritic cells and innate lymphocytes.
Wohn CT; Pantelyushin S; Ober-Blöbaum JL; Clausen BE
Methods Mol Biol; 2014; 1193():171-85. PubMed ID: 25151006
[TBL] [Abstract][Full Text] [Related]
17. Sun exposure rapidly reduces plasmacytoid dendritic cells and inflammatory dermal dendritic cells in psoriatic skin.
Heier I; Søyland E; Krogstad AL; Rodríguez-Gallego C; Nenseter MS; Jahnsen FL
Br J Dermatol; 2011 Oct; 165(4):792-801. PubMed ID: 21623747
[TBL] [Abstract][Full Text] [Related]
18. Natural Modulators of Endosomal Toll-Like Receptor-Mediated Psoriatic Skin Inflammation.
Lai CY; Su YW; Lin KI; Hsu LC; Chuang TH
J Immunol Res; 2017; 2017():7807313. PubMed ID: 28894754
[TBL] [Abstract][Full Text] [Related]
19. Epicutaneous application of toll-like receptor 7 agonists leads to systemic autoimmunity in wild-type mice: a new model of systemic Lupus erythematosus.
Yokogawa M; Takaishi M; Nakajima K; Kamijima R; Fujimoto C; Kataoka S; Terada Y; Sano S
Arthritis Rheumatol; 2014 Mar; 66(3):694-706. PubMed ID: 24574230
[TBL] [Abstract][Full Text] [Related]
20. Gene expression in actinic keratoses: pharmacological modulation by imiquimod.
Lysa B; Tartler U; Wolf R; Arenberger P; Benninghoff B; Ruzicka T; Hengge UR; Walz M
Br J Dermatol; 2004 Dec; 151(6):1150-9. PubMed ID: 15606509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
